New Enterprise Associates

News, insights, analysis and data

← Back to New Enterprise Associates profile

New Enterprise Associates related stories

All articles and analysis

  • VC-Backed GridPoint Buys ADDMMicro
    VCJ Staff- 9 November 2009

    GridPoint Inc., an Arlington, Va.-based smart-grid company, has acquired ADMMicro, a Roanoke, Va.-based provider of energy management systems for the commercial and industrial sector. No financial terms were disclosed. GridPoint has raised around $220 million in total VC funding, from firms like Goldman Sachs, New Enterprise Associates, Susquehanna Private Equity, Perella Weinberg Partners and Robeco.

  • Apprenda Raises $5 Million
    VCJ Staff- 9 November 2009

    Apprenda, an Albany, N.Y.-based developer of an SaaS application server, has raised $5 million in new VC funding. New Enterprise Associates led the round, and was joined by return backer High Peaks Capital.

  • Week in deals, Nov. 9, 2009
    Brad Meikle- 9 November 2009

    Summary of North American tech companies and other startups that raised venture financing in the past week

  • peHUB Wire: Friday, October 30, 2009
    Brad Meikle- 9 November 2009

    The Buyout of America

  • peHUB Wire: Friday, October 30, 2009
    Brad Meikle- 9 November 2009

    The Buyout of America

  • Zyngenia Raises $10 Million
    VCJ Staff- 5 November 2009

    Zyngenia Inc., a Rockville, Md.-based pharma startup focused on antibody development, has raised $10 million in Series A funding from New Enterprise Associates.

  • peHUB Wire: Thursday, November 5, 2009
    Brad Meikle- 5 November 2009
  • peHUB Wire: Thursday, November 5, 2009
    Brad Meikle- 5 November 2009
  • 23andMe Hits Some Bumps
    debbiegage- 3 November 2009

    In May, Dan reported /38928/23andme-raises-at-least-11-million/ that Mohr Davidow Ventures had sold its small stake in personal genomics company 23andMe -- famous partly because of its co-founder, Anne Wojcicki, who's married to Google co-founder Sergey Brin -- and invested in rival Navigenics. Both companies analyze your DNA and report if you are predisposed to certain genetic diseases. Mohr Davidow's Sue Siegel said today that although her firm's parting with 23andMe was amicable, the two did not see eye-to-eye on what role venture capitalists should play. Mohr Davidow's limited partners require the firm to take board seats with companies they invest in, she said, and 23andMe didn't want venture capitalists on the board. "We have a fiduciary duty to watch our investments, and when we commit we need to take board seats," Siegel said. "I think that's more of a norm than an exception."

  • Week in deals, Nov. 2, 2009
    Brad Meikle- 2 November 2009

    Summary of North American tech companies and other startups that raised venture financing in the past week